These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 326974)

  • 1. A comparison of therapeutic efficacy and toxicity of ethionamide and prothionamide in Indian patients.
    Gupta DK; Mital OP; Agarwal MC; Kansal HM; Nath S
    J Indian Med Assoc; 1977 Jan; 68(2):25-9. PubMed ID: 326974
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative clinical study of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Shmelev NA; Korotaev GA; Poleshchuk AK; Utkin VV; Golitsyna LV
    Probl Tuberk; 1969; 47(1):27-33. PubMed ID: 5380204
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative characteristics of the effectiveness and tolerance of ethionamide and prothionamide in the clinical treatment of pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Probl Tuberk; 1973; 51(10):37-40. PubMed ID: 4784035
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bacteriostatic activity of blood in single and combined use of ethionamide or prothionamide].
    Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1975; (5):70-3. PubMed ID: 1144350
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of patients with pulmonary tuberculosis, complicated by peptic ulcer, with ethionamide and prothionamide].
    Samtsov VS
    Probl Tuberk; 1973; 51(7):67-70. PubMed ID: 4767522
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical results obtained with Isoprodian in the treatment of new cases of pulmonary tuberculosis.
    Sighart H
    Scand J Respir Dis Suppl; 1978; 102():60-1. PubMed ID: 356259
    [No Abstract]   [Full Text] [Related]  

  • 7. [Concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Vrach Delo; 1973 Nov; 11():97-100. PubMed ID: 4206857
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protionamide tolerance in patients with pulmonary tuberculosis showing poor tolerance to ethionamide].
    Utkin VV; Zankisova IG; Poleshchuk AK; Krylova NP; Gridneva SM
    Vrach Delo; 1971 Nov; 11():79-81. PubMed ID: 5143287
    [No Abstract]   [Full Text] [Related]  

  • 9. Further data on the effect of ethionamide and prothionamide in experimental leprosy.
    Pattyn SR
    Lepr Rev; 1978 Sep; 49(3):199-202. PubMed ID: 692251
    [No Abstract]   [Full Text] [Related]  

  • 10. [Isoprodian in ambulatory therapy of pulmonary tuberculosis].
    Opl G; Novak M
    Prax Klin Pneumol; 1980 Dec; 34(12):715-8. PubMed ID: 7465531
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.
    Fajardo TT; Guinto RS; Cellona RV; Abalos RM; Dela Cruz EC; Gelber RH
    Am J Trop Med Hyg; 2006 Mar; 74(3):457-61. PubMed ID: 16525107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of acute intolerance to ethionamide, including a comparison with prothionamide, and of the influence of a vitamin B-complex additive in prophylaxis.
    Fox W; Robinson DK; Tall R; Kent PW; Macfadyen DM
    Tubercle; 1969 Jun; 50(2):125-43. PubMed ID: 4894707
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review.
    Colston MJ; Ellard GA; Gammon PT
    Lepr Rev; 1978 Jun; 49(2):115-26. PubMed ID: 661479
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new therapeutic approach to open pulmonary tuberculosis with a combination of isoniazid, prothionamid and dapson (author's transl)].
    González Montaner LF; Garay C; Abbate EH; Albareda MA
    Prax Klin Pneumol; 1978 Jul; 32(7):488-90. PubMed ID: 98759
    [No Abstract]   [Full Text] [Related]  

  • 15. [Isoniazio, prothionamide and diafenylsulphone (isoprodian) in the therapy of previously untreated pulmonary (author's transl)].
    Müller W
    Prax Pneumol; 1976 Mar; 30(3):157-64. PubMed ID: 785434
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolerability and efficacy of isoprodian-containing antituberculosis regimens.
    Kleeberg HH
    S Afr Med J; 1986 Feb; 69(3):161. PubMed ID: 3511545
    [No Abstract]   [Full Text] [Related]  

  • 17. [A preliminary report on the clinical efficacy of isoprodian (author's transl)].
    Opl G; Benkö M
    Prax Pneumol; 1976 Mar; 30(3):154-7. PubMed ID: 785433
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the toxicity of prothionamide and ethionamide: a report from the research committee of the British Tuberculosis Association.
    Tubercle; 1968 Jun; 49(2):125-35. PubMed ID: 5243159
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis by polarographic method].
    Tikhonov VA; Grigaliunas AP; Guzeeva SA
    Probl Tuberk; 1976 May; (5):75-8. PubMed ID: 951413
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of therapeutic effect and side actions of 1314 TH and 1321 TH in the initial therapy of tuberculosis].
    Sunahara S; Nagasawa S
    Saishin Igaku; 1969 Apr; 24(4):922-7. PubMed ID: 5807960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.